| Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ... Jama 318 (23), 2306-2316, 2017 | 2063 | 2017 |
| Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial DA Reardon, AA Brandes, A Omuro, P Mulholland, M Lim, A Wick, ... JAMA oncology 6 (7), 1003-1010, 2020 | 950 | 2020 |
| Brain metastases AS Achrol, RC Rennert, C Anders, R Soffietti, MS Ahluwalia, L Nayak, ... Nature Reviews Disease Primers 5 (1), 5, 2019 | 776 | 2019 |
| Management of brain metastases in tyrosine kinase inhibitor-naïve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis WJ Magnuson, NH Lester-Coll, AJ Wu, TJ Yang, NA Lockney, NK Gerber, ... J Clin Oncol 35 (10), 1070-1077, 2017 | 452 | 2017 |
| Current approaches to the management of brain metastases JH Suh, R Kotecha, ST Chao, MS Ahluwalia, A Sahgal, EL Chang Nature reviews Clinical oncology 17 (5), 279-299, 2020 | 360 | 2020 |
| OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143 DA Reardon, A Omuro, AA Brandes, J Rieger, A Wick, J Sepulveda, ... Neuro-oncology 19 (suppl_3), iii21-iii21, 2017 | 337 | 2017 |
| Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology LB Nabors, J Portnow, M Ahluwalia, J Baehring, H Brem, S Brem, ... Journal of the National Comprehensive Cancer Network 18 (11), 1537-1570, 2020 | 333 | 2020 |
| Challenges with the diagnosis and treatment of cerebral radiation necrosis ST Chao, MS Ahluwalia, GH Barnett, GHJ Stevens, ES Murphy, ... International Journal of Radiation Oncology* Biology* Physics 87 (3), 449-457, 2013 | 306 | 2013 |
| Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme DM Peereboom, DR Shepard, MS Ahluwalia, CJ Brewer, N Agarwal, ... Journal of neuro-oncology 98, 93-99, 2010 | 248 | 2010 |
| Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma AE Sloan, MS Ahluwalia, J Valerio-Pascua, S Manjila, MG Torchia, ... Journal of neurosurgery 118 (6), 1202-1219, 2013 | 239 | 2013 |
| The evolving landscape of brain metastasis M Valiente, MS Ahluwalia, A Boire, PK Brastianos, SB Goldberg, EQ Lee, ... Trends in cancer 4 (3), 176-196, 2018 | 226 | 2018 |
| Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group I Thibault, EL Chang, J Sheehan, MS Ahluwalia, M Guckenberger, ... The Lancet Oncology 16 (16), e595-e603, 2015 | 197 | 2015 |
| Whole-brain radiotherapy for brain metastases: evolution or revolution? PD Brown, MS Ahluwalia, OH Khan, AL Asher, JS Wefel, V Gondi Journal of Clinical Oncology 36 (5), 483, 2018 | 194 | 2018 |
| Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis TJ Alban, AG Alvarado, MD Sorensen, D Bayik, J Volovetz, E Serbinowski, ... JCI insight 3 (21), 2018 | 170 | 2018 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis M Ahluwalia, GH Barnett, D Deng, SB Tatter, AW Laxton, AM Mohammadi, ... Journal of neurosurgery 130 (3), 804-811, 2018 | 166 | 2018 |
| ANG1005, a brain-penetrating peptide–drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases P Kumthekar, SC Tang, AJ Brenner, S Kesari, DE Piccioni, C Anders, ... Clinical Cancer Research 26 (12), 2789-2799, 2020 | 163 | 2020 |
| Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner D Bayik, Y Zhou, C Park, C Hong, D Vail, DJ Silver, A Lauko, G Roversi, ... Cancer discovery 10 (8), 1210-1225, 2020 | 155 | 2020 |
| Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma RA Fenstermaker, MJ Ciesielski, J Qiu, N Yang, CL Frank, KP Lee, ... Cancer immunology, immunotherapy 65, 1339-1352, 2016 | 145 | 2016 |
| Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies MS Ahluwalia, J de Groot, WM Liu, CL Gladson Cancer letters 298 (2), 139-149, 2010 | 139 | 2010 |
Samuel ChaoAssociate Professor, Cleveland Clinic Lerner College of MedicineVerified email at ccf.org
